[1]MocormickD , HallPA .Thecomplexitiesofproliferatingcellnuclearanti gen[J].Histopathology, 1992, 21∶591-594.
|
[2]黄志清, 阚秀, 虞有智, 等乳腺癌中PCNA表达及其与组织学分级的关系[J].临床与实验病理学杂志, 1996, 12 (4) ∶295-296
|
[3]扬竹林, 钟德, 李永国, 等.胆系恶性肿瘤增殖细胞核抗原表达及其意义[J].中华外科杂志, 1995, 33 (7) ∶437-438.
|
[4]薛凤霞, 焦书竹, 王海燕, 等.子宫内膜癌PCAN表达的研究[J].中国肿瘤临床, 1997, 24 (6) ∶427-430.
|
[5]吴秉铨, 李玲HER -2/neu基因在乳腺癌研究进展的启迪.[J].中华病理学杂志, 2002, 31 (3) ∶197-198.
|
[2] | Xu Hua, Xiong JianPing. The expression of tumor suppressor gene PTEN in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2004, 20(3): 172-173. |
[3] | Zhang YaoMing, Gao YanMing, Li Rong, Zhang KeJun, Zuo ChaoHai, Li ChengCai. Expression of PTTG and bFGF in primary gallbladder cancer and their clinical significance[J]. Journal of Clinical Hepatology, 2004, 20(2): 108-110. |
[5] | Wang YangKun, Ma ZhaoXu, Ding JiYuan, Li Yong, Lou HaiLing. p53 in situ hybridization and nm23 expression of gallbladder carcinoma and its relationship with lymphoproliferation[J]. Journal of Clinical Hepatology, 2001, 17(2): 109-111. |
[6] | Zhang JinXia, Liu Tong, Yang ChunMing. Immunohistochemistry analysis of expression of PTEN, p53 suppressor gene in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2001, 17(3): 184-185. |